Cite
Targeted inhibition of ANKRD1 disrupts sarcomeric ERK-GATA4 signal transduction and abrogates phenylephrine-induced cardiomyocyte hypertrophy.
MLA
Zhong, Lin, et al. “Targeted Inhibition of ANKRD1 Disrupts Sarcomeric ERK-GATA4 Signal Transduction and Abrogates Phenylephrine-Induced Cardiomyocyte Hypertrophy.” Cardiovascular Research, vol. 106, no. 2, May 2015, pp. 261–71. EBSCOhost, https://doi.org/10.1093/cvr/cvv108.
APA
Zhong, L., Chiusa, M., Cadar, A. G., Lin, A., Samaras, S., Davidson, J. M., & Lim, C. C. (2015). Targeted inhibition of ANKRD1 disrupts sarcomeric ERK-GATA4 signal transduction and abrogates phenylephrine-induced cardiomyocyte hypertrophy. Cardiovascular Research, 106(2), 261–271. https://doi.org/10.1093/cvr/cvv108
Chicago
Zhong, Lin, Manuel Chiusa, Adrian G. Cadar, Angel Lin, Susan Samaras, Jeffrey M. Davidson, and Chee C. Lim. 2015. “Targeted Inhibition of ANKRD1 Disrupts Sarcomeric ERK-GATA4 Signal Transduction and Abrogates Phenylephrine-Induced Cardiomyocyte Hypertrophy.” Cardiovascular Research 106 (2): 261–71. doi:10.1093/cvr/cvv108.